All In Biotech

Drug Trial Radar · NCT00000844

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3

Last checked: Nov 20, 2026Latest source record: Nov 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

560

Actual

Start

Not stated

Primary completion

Not stated

Study completion Jun 2002

Sponsor

Sponsor type
NIH
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the effects of three preparations of low-dose oral interferon alpha (i.e., Alferon LDO, Veldona, and Ferimmune) on HIV symptoms in HIV-infected patients. To evaluate differences in response to oral interferon alpha according to gender, race/ethnicity, and use of antiretrovirals. Previous or ongoing clinical trials to test the efficacy of low-dose oral interferon alpha have produced different results, and it is not clear whether the differences were due to the interferon alpha products used or to problems in the study design. Therefore, three preparations will be compared to evaluate their potential efficacies.

Conditions

  • HIV Infections

Interventions

  • Interferon alfa-n3Drug

  • Interferon alfa-n1Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • King - Drew Med Ctr

    Los Angeles, California

  • AIDS Community Research Consortium

    Redwood City, California

  • Yale Univ / New Haven

    New Haven, Connecticut

  • Med Ctr of Delaware / Wilmington Hosp

    Wilmington, Delaware

  • Georgetown Univ Med Ctr

    Washington D.C., District of Columbia

  • Abundant Life Clinic Foundation

    Washington D.C., District of Columbia

  • Howard Univ Hosp

    Washington D.C., District of Columbia

  • Henry Ford Hosp

    Detroit, Michigan

  • Univ of Minnesota Hosp

    Minneapolis, Minnesota

  • SUNY / Health Sciences Ctr at Brooklyn

    Brooklyn, New York

  • Dr Barbara Justice

    New York, New York

  • Harlem AIDS Treatment Group / Harlem Hosp Ctr

    New York, New York

  • New York Med College / Westchester County Med Ctr

    Valhalla, New York

  • Univ of Pennsylvania Med Ctr

    Philadelphia, Pennsylvania

  • Meharry Med College

    Nashville, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.